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Analysis of Genetic Alterations in Primary Nasopharyngeal Carcinoma by Comparative 
Genomic Hybridization (CGH). L. Sun1, Y. Fong2, J.S.T. Sham3, Y. Guo2, M. Deng2, Q. Liang2, 
H. Zhang4, H. Zhou4, H. Tideman1, J.M. Trent4, X.-Y. Guan3. 1) Oral Maxillofacial Surgery, The 
University of Hong Kong, Hong Kong, PR China; 2) Cancer Center, Sun Yat-sen University of 
Medical Sciences, China; 3) Department of Clinical Oncology, The University of Hong Kong, 
Hong Kong; 4) Cancer Genetics Branch, NHGRI, NIH, Bethesda, MD. 
   To identify genetic alterations associated with the development and progression of human 
nasopharyngeal carcinoma (NPC), 57 tumors were analyzed using comparative genomic 
hybridization (CGH). In 47 cases chromosomal imbalances were found. Several recurrent 
chromosomal abnormalities were identified in the present study. The most frequently detected 
chromosomal gains involved chromosomes 12q (24 cases, 51%), 4q (17 cases, 36%), 3q (16 
cases, 34%), 1q (15 cases, 32%), and 18q (15 cases, 32%). Common regions of gain involved 
12q13-q15, 4q12-q21, and 3q21-q26. High copy number increases of chromosomal materials 
were detected in 4 chromosomal regions, 3q21-q26.2, 4p12-q21, 8p, and 12q14-q15. The most 
frequently detected loss of chromosomal materials involved chromosomes 16q (26 cases, 55%), 
14q (21 cases, 45%), 1p (20 cases, 43%), 3p (20 cases, 43%), 16p (19 cases, 40%) 11q (17 
cases, 36%) and 19p (16 cases, 34%). The most common regions of loss involved 14q24-qter, 
1pter-p36.1, 3p22-p21.3, 11q21-qter, and the distal region of 19p respectively. Genomic 
alterations detected using CGH were compared and found to be largely consistent with those 
identified using banding analysis and loss of heterozygosity studies. However, several 
previously unrecognized recurrent alterations were also identified in the present study including: 
gain of 4q and 18q, and loss of 16q, 14q, and 19p. In addition, gain of 1q, 8q, 18q, and loss of 
9q showed statistically significant association with advanced clinical stage (p<0.05). 
Identification of recurrent sites of chromosomal gain and loss identify regions of the genome 
that may contain oncogenes or tumor suppressor genes respectively which maybe involved in 
the tumorigenesis of NPC. 
 
